Session Chair Profile

Ph.D., Partner, DeciBio Consulting

Dr. Stephane Budel is a partner at DeciBio Consulting with over 18 years of combined experience in life science business consulting, entrepreneurship and academic research. He specializes in helping companies commercialize novel and disruptive technologies in the life science research tools and diagnostic spaces. He has deep genomics expertise, especially as it relates to the impact of next generation sequencing. He has supported clients facing a broad range of challenging business issues, including product specification strategy and commercial due diligence. Dr. Budel earned his Ph.D. from Yale University for his research on the molecular mechanisms of schizophrenia.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

View the top 3 talks from PMWC here (password: top-videos).